Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MEXC has launched "Crypto Fever," that Users can complete simple tasks, spin the wheel, and share $200,000 in rewards.
-
Reykjavik, March 20, 2026 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Notice of Full Year Results and Investor Presentation TORONTO, ONTARIO – 20 March 2026 – Amaroq Ltd. (AIM, TSX-V,...
-
SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
-
The 2026 Skagit Valley Tulip Festival may begin earlier than usual, with blooms expected up to two weeks ahead of schedule due to warmer weather.
-
SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) -- Endeavor Bancorp (OTCQX: EDVR), based in San Diego, focused on Southern California business banking with a consultative model, today announced that Dan...
-
FAIRMONT, W.Va, March 19, 2026 (GLOBE NEWSWIRE) -- MVB Financial Corp. (NASDAQ: MVBF), an innovative bank focused on powering solutions for leading Fintech companies nationwide, while providing...
-
ROCHESTER, N.Y., March 19, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its full fiscal...
-
CAMBRIDGE, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
-
HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE:ORN) (“Orion” or the “Company”), a leading specialty construction company, today announced new contract awards and change...
-
SAN JOSE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...